Pms-Irbesartan-Hctz 12.5 mg (Hydrochlorothiazide TABLET) 12.5 MG

PMS-IRBESARTAN-HCTZ 12.5 MG tablets combine irbesartan and hydrochlorothiazide for blood pressure management. This oral medication is designed to support cardiovascular health.

Strength

12.5 MG

Pack Size

100

Manufacturer / TM Owner

PHARMASCIENCE INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

PMS-IRBESARTAN-HCTZ 12.5 MG tablets are commonly used to manage high blood pressure. The combination of irbesartan, an angiotensin II receptor blocker, and hydrochlorothiazide, a diuretic, works to lower blood pressure. This medication is often prescribed for individuals who require dual-action therapy to control hypertension.

Side Effects

When taken as directed, PMS-IRBESARTAN-HCTZ 12.5 MG tablets may help reduce blood pressure levels. Some users may experience common effects such as dizziness, fatigue, or mild dehydration due to the diuretic component. It is important to stay hydrated while using this medication.

Precautions & Warnings

PMS-IRBESARTAN-HCTZ 12.5 MG tablets should be handled with care. It is essential to follow the prescribed dosage and consult a healthcare provider before starting or stopping this medication. Individuals with certain medical conditions, such as kidney disease, should discuss potential risks with their healthcare provider.

Avoid Interactions

PMS-IRBESARTAN-HCTZ 12.5 MG tablets may interact with other medications, including certain pain relievers, NSAIDs, and other blood pressure medications. Alcohol consumption should be limited, as it can enhance the effects of the diuretic component. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

PMS-IRBESARTAN-HCTZ 12.5 MG tablets are used to manage high blood pressure by combining irbesartan and hydrochlorothiazide.

PMS-IRBESARTAN-HCTZ 12.5 MG tablets are taken orally, typically once daily, as prescribed by a healthcare provider.

Common effects may include dizziness, fatigue, and mild dehydration due to the diuretic component.

PMS-IRBESARTAN-HCTZ 12.5 MG may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Alcohol consumption should be limited while taking PMS-IRBESARTAN-HCTZ 12.5 MG, as it can enhance the effects of the diuretic component.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.